Susanne Nikolaus Selected Research

Dopamine (Intropin)

1/2022	Monoaminergic hypo- or hyperfunction in adolescent and adult attention-deficit hyperactivity disorder?
10/2020	Altered dopaminergic pathways and therapeutic effects of intranasal dopamine in two distinct mouse models of autism.
1/2019	Acute anxiety disorder, major depressive disorder, bipolar disorder and schizophrenia are related to different patterns of nigrostriatal and mesolimbic dopamine dysfunction.
1/2017	Different patterns of dopaminergic and serotonergic dysfunction in manic, depressive and euthymic phases of bipolar disorder.
1/2010	Cortical GABA, striatal dopamine and midbrain serotonin as the key players in compulsive and anxiety disorders--results from in vivo imaging studies.
12/2009	In vivo imaging of synaptic function in the central nervous system: II. Mental and affective disorders.
12/2009	In vivo imaging of synaptic function in the central nervous system: I. Movement disorders and dementia.
1/2007	Investigating the dopaminergic synapse in vivo. I. Molecular imaging studies in humans.
1/2007	Investigating the dopaminergic synapse in vivo. II. Molecular imaging studies in small laboratory animals.
3/2006	Striatal dopamine transporter density in drug naive patients with attention-deficit/hyperactivity disorder.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Susanne Nikolaus Research Topics

Disease

6	Parkinson Disease (Parkinson's Disease) 05/2015 - 03/2003
5	Schizophrenia (Dementia Praecox) 01/2022 - 12/2009
4	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 01/2022 - 03/2006
4	Bipolar Disorder (Manic Depressive Psychosis) 01/2019 - 07/2012
4	Major Depressive Disorder (Major Depressive Disorders) 01/2019 - 12/2009
4	Anxiety Disorders (Anxiety Disorder) 01/2019 - 12/2009
3	Huntington Disease (Huntington's Disease) 01/2007 - 01/2004
2	Alzheimer Disease (Alzheimer's Disease) 01/2018 - 12/2009
2	Mania (Manias) 01/2017 - 07/2012
2	Obsessive-Compulsive Disorder (Disorder, Obsessive-Compulsive) 01/2010 - 12/2009
2	Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder) 01/2010 - 12/2009
2	Corticobasal Degeneration 12/2009 - 01/2007
2	Dementia (Dementias) 12/2009 - 01/2007
2	Multiple System Atrophy 12/2009 - 01/2007
2	Progressive Supranuclear Palsy (Steele Richardson Olszewski Syndrome) 12/2009 - 01/2007
1	Autistic Disorder (Autism) 10/2020
1	Neurodevelopmental Disorders 10/2020
1	Intellectual Disability (Idiocy) 10/2020
1	Autism Spectrum Disorder 10/2020
1	Neuroinflammatory Diseases 01/2018
1	Gliosis 01/2018
1	Parkinsonian Disorders (Parkinsonism) 05/2011
1	Phobic Disorders (Phobia) 01/2010
1	Panic Disorder (Panic Attack) 01/2010
1	Tourette Syndrome (Tourette's Syndrome) 12/2009
1	Frontotemporal Dementia (Semantic Dementia) 12/2009
1	Borderline Personality Disorder (Personality Disorders, Borderline) 12/2009
1	Substance-Related Disorders (Drug Abuse) 01/2007

Drug/Important Bio-Agent (IBA)

10	Dopamine (Intropin)FDA LinkGeneric 01/2022 - 03/2006
4	Serotonin (5 Hydroxytryptamine)IBA 01/2022 - 12/2009
4	Dopamine Plasma Membrane Transport Proteins (Dopamine Transporter)IBA 12/2009 - 03/2006
3	Neurotransmitter Agents (Neurotransmitter)IBA 01/2018 - 07/2012
2	Acetylcholine (Acetylcholine Chloride)FDA Link 01/2017 - 12/2009
2	Oxidopamine (6 Hydroxydopamine)IBA 05/2015 - 03/2003
2	Cholinergic Agents (Cholinergics)IBA 12/2009 - 01/2004
2	Cocaine (Cocaine HCl)IBA 01/2007 - 01/2004
1	Proteins (Proteins, Gene)FDA Link 01/2022
1	Norepinephrine (Noradrenaline)FDA LinkGeneric 01/2022
1	Brachyury protein (Brachyury)IBA 10/2020
1	Therapeutic UsesIBA 10/2020
1	Amyloid beta-PeptidesIBA 01/2018
1	Serotonin ReceptorsIBA 01/2016
1	AutoreceptorsIBA 01/2014
1	5-HT2A Serotonin Receptor (5 HT2A Receptor)IBA 07/2012
1	Levodopa (L Dopa)FDA LinkGeneric 02/2012
1	3- iodo- 2- hydroxy- 6- methoxy- N- ((1- ethyl- 2- pyrrolidinyl)methyl)benzamideIBA 05/2011
1	2- carbomethoxy- 8- (3- fluoropropyl)- 3- (4- iodophenyl)tropaneIBA 05/2011
1	3-Iodobenzylguanidine (Iobenguane)IBA 05/2011
1	gamma-Aminobutyric Acid (GABA)IBA 01/2010
1	Serotonin Plasma Membrane Transport Proteins (Serotonin Transporter)IBA 12/2009
1	Cholinergic ReceptorsIBA 12/2009
1	GABA-A Receptors (GABA(A) Receptor)IBA 12/2009
1	Nicotine FDA Link 01/2007
1	Methylphenidate (Ritalin)FDA LinkGeneric 01/2007
1	Amphetamine (Amfetamine)FDA LinkGeneric 01/2007
1	Heroin (Diamorphine)IBA 01/2007
1	Nerve Growth Factors (Neurotrophins)IBA 01/2004
1	Dopamine Receptors (Dopamine Receptor)IBA 01/2004

Therapy/Procedure

1	Injections 05/2015
1	Therapeutics 02/2012